They would easily pay 5-10c when they would be convinced that the MC could reach $500m when both, GBM and AML get their rego trials approved by the FDA and that when they get FDA drug approval the MC will reach the $billion range.
Assuming 1.7b shares on issue after those 800m, the sp would be at 25-30c and then reach the $ range. That is what the chair needs to present after the COO / CMO has presented the incredible science and the peer comparison. I would achieve exactly that having those data as back up. But it takes to be present at those presentations and show the fighting spirit. If you want to sell a Ferrari you can't sell it the dull way like selling a Fiat 500.
Steini, you are arrogant, nobody could sell it that way. Really? If ALA can sell NOTHING for a lot, I can sell a LOT for a decent amount.
That's why I have started contacting top 20 holders to put pressure on Hopper. If we want things to improve we have to start somewhere. Just complaining on HC won't change anything.
GLTA
CHM Price at posting:
2.1¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)